Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT02530502 · TERMINATED
Trial details
- NCT number
- NCT02530502
- Sponsor
- Northwestern University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-30
- Primary completion
- 2016-05-10
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.